Literature DB >> 22468185

Tumors of ampulla of Vater: A case series and review of chemotherapy options.

Adriana Romiti1, Viola Barucca, Angelo Zullo, Ida Sarcina, Roberta Di Rocco, Chiara D'Antonio, Marco Latorre, Paolo Marchetti.   

Abstract

Carcinomas of the Ampulla of Vater are rare tumors, accounting for 0.2% of gastrointestinal cancers. Compared with other biliary tract neoplasms, these tumors have a relatively favorable prognosis after surgical resection. Based on their epithelium of origin, two subtypes of ampullary carcinoma have been recently distinguished: intestinal and pancreatobiliary. This study evaluates histopathological features and outcomes of ampullary carcinoma and to compares the survival of these tumors to that of other biliary tract tumors. The chemotherapic options available for ampullary cancer are also reviewed. We analyzed data from 20 consecutive patients with ampullary carcinomas and 26 patients with other biliary tract carcinomas, observed in our Institution. Statistical analysis was performed by using either Fisher's exact test or χ(2) test for categorical variables. Median time of survival was calculated and compared using the Log-Rank test. Similar distribution of demographic characteristics and stage between ampullary and other biliary tract cancers was observed. Patients with ampullary cancer underwent surgery more frequently than other biliary cancers while chemotherapy and radiotherapy were used equally. In accordance with the literature, a longer median survival was observed in the group of ampullary carcinomas.

Entities:  

Keywords:  Ampullary carcinoma; Biliary tract cancer; Chemotherapy; Radiotherapy

Year:  2012        PMID: 22468185      PMCID: PMC3312930          DOI: 10.4251/wjgo.v4.i3.60

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  68 in total

1.  Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.

Authors:  Hui Zhou; Nico Schaefer; Martin Wolff; Hans-Peter Fischer
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

2.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

3.  Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.

Authors:  Kyubo Kim; Eui Kyu Chie; Jin-Young Jang; Sun Whe Kim; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung W Ha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-23       Impact factor: 7.038

4.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

5.  Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival.

Authors:  S M M de Castro; N T van Heek; K F D Kuhlmann; O R C Busch; G J A Offerhaus; T M van Gulik; H Obertop; D J Gouma
Journal:  Surgery       Date:  2004-11       Impact factor: 3.982

6.  Survival after resection of ampullary carcinoma: a national population-based study.

Authors:  Jessica B O'Connell; Melinda A Maggard; Jesse Manunga; James S Tomlinson; Howard A Reber; Clifford Y Ko; O Joe Hines
Journal:  Ann Surg Oncol       Date:  2008-03-28       Impact factor: 5.344

7.  Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma.

Authors:  Myung Ah Lee; In Sook Woo; Jin-Hyoung Kang; Young Seon Hong; Kyung Shik Lee
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-28       Impact factor: 4.553

8.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

9.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Is endosonography an effective method for detection and local staging of the ampullary carcinoma? A prospective study.

Authors:  Panagiotis Skordilis; Ioannis A Mouzas; Philippos D Dimoulios; Georgios Alexandrakis; Joanna Moschandrea; Elias Kouroumalis
Journal:  BMC Surg       Date:  2002-03-25       Impact factor: 2.102

View more
  12 in total

1.  Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.

Authors:  Nana Aburjania; Alexander M Truskinovsky; Michael J Overman; Emil Lou
Journal:  J Gastrointest Cancer       Date:  2014-03

2.  A case of periampullary adenocarcinoma in neurofibromatosis type 1.

Authors:  C Andrew Kistler; Jennifer M Johnson; Jordan M Winter; Jeffrey P Baliff; Ali A Siddiqui; Ashwin R Sama
Journal:  J Gastrointest Oncol       Date:  2014-12

Review 3.  [Papillary tumors - therapeutic concepts].

Authors:  F C Popp; J Weigt; T Kalinski; C Betzler; J Arend; B Garlipp; C Benckert; C J Bruns
Journal:  Chirurg       Date:  2015-08       Impact factor: 0.955

4.  Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.

Authors:  Hye Jin Choi; Chang Moo Kang; Kwanhyeong Jo; Woo Jung Lee; Jae-Hoon Lee; Young Hoon Ryu; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-13       Impact factor: 9.236

5.  Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.

Authors:  Marie-Claude Gingras; Kyle R Covington; David K Chang; Lawrence A Donehower; Anthony J Gill; Michael M Ittmann; Chad J Creighton; Amber L Johns; Eve Shinbrot; Ninad Dewal; William E Fisher; Christian Pilarsky; Robert Grützmann; Michael J Overman; Nigel B Jamieson; George Van Buren; Jennifer Drummond; Kimberly Walker; Oliver A Hampton; Liu Xi; Donna M Muzny; Harsha Doddapaneni; Sandra L Lee; Michelle Bellair; Jianhong Hu; Yi Han; Huyen H Dinh; Mike Dahdouli; Jaswinder S Samra; Peter Bailey; Nicola Waddell; John V Pearson; Ivon Harliwong; Huamin Wang; Daniela Aust; Karin A Oien; Ralph H Hruban; Sally E Hodges; Amy McElhany; Charupong Saengboonmee; Fraser R Duthie; Sean M Grimmond; Andrew V Biankin; David A Wheeler; Richard A Gibbs
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

Review 6.  Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review.

Authors:  Zhiqing Duan; Yinuo Zhang; Yajie Tang; Ruqing Gao; Jing Bao; Bo Liang
Journal:  Transl Oncol       Date:  2022-04-06       Impact factor: 4.243

7.  Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.

Authors:  Jacob Elebro; Margareta Heby; Alexander Gaber; Björn Nodin; Liv Jonsson; Richard Fristedt; Mathias Uhlén; Karin Jirström; Jakob Eberhard
Journal:  J Transl Med       Date:  2014-10-17       Impact factor: 5.531

8.  Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.

Authors:  Emelie Karnevi; Liv Ben Dror; Adil Mardinoglu; Jacob Elebro; Margareta Heby; Sven-Erik Olofsson; Björn Nodin; Jakob Eberhard; William Gallagher; Mathias Uhlén; Karin Jirström
Journal:  Oncotarget       Date:  2017-12-15

Review 9.  Ampulla of Vater carcinoma: Molecular landscape and clinical implications.

Authors:  Antonio Pea; Giulio Riva; Riccardo Bernasconi; Elisabetta Sereni; Rita Teresa Lawlor; Aldo Scarpa; Claudio Luchini
Journal:  World J Gastrointest Oncol       Date:  2018-11-15

10.  Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.

Authors:  Michael Feretis; Tengyao Wang; Satheesh Iype; Adam Duckworth; Rebecca Brais; Bristi Basu; Neville V Jamieson; Emmanuel Huguet; Anita Balakrishnan; Asif Jah; Raaj K Praseedom; Simon J Harper; Siong-Seng Liau
Journal:  Pancreas       Date:  2017 Nov/Dec       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.